« PreviousNext »Journal of the American College of Surgeons
Volume 209, Issue 1 , Pages 68-74, July 2009
Volume 209, Issue 1 , Pages 68-74, July 2009
A Phase 3b, Open-Label, Single-Group Immunogenicity and Safety Study of Topical Recombinant Thrombin in Surgical Hemostasis
To access this article, please choose from the options below
Disclosure Information: The clinical study was funded by ZymoGenetics, Inc. Dr Alexander is employed by ZymoGenetics, Inc as medical director, and the remaining authors were clinical investigators for this study.
The ClinicalTrials.gov identifier for this study is NCT00491608.
PII: S1072-7515(09)00325-1
doi:10.1016/j.jamcollsurg.2009.03.016
© 2009 American College of Surgeons. Published by Elsevier Inc. All rights reserved.
« PreviousNext »Journal of the American College of Surgeons
Volume 209, Issue 1 , Pages 68-74, July 2009
Volume 209, Issue 1 , Pages 68-74, July 2009
